FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991036726> ?p ?o ?g. }

• W1991036726 endingPage "465" @default.
• W1991036726 startingPage "457" @default.
• W1991036726 abstract "To assess the effect of end-stage renal failure on oxidized low-density lipoprotein (OxLDL) biomarkers and the acute effects of hemodialysis. Oxidized phospholipids (OxPL) on apolipoprotein B-100 (apoB) particles (OxPL/apoB) have been associated with cardiovascular disease and new cardiovascular events. Patients with end-stage renal failure have increased oxidative stress and are at significantly increased risk of cardiovascular disease.Fifty-two stable patients with end-stage renal failure undergoing chronic hemodialysis were included in the study. Pre and post hemodialysis blood samples were obtained for measurement of OxLDL biomarkers: oxidized phospholipids (OxPL) on apolipoprotein B-100 (apoB) particles (OxPL/apoB) measured by antibody E06, IgG and IgM autoantibody titers to copper-oxidized LDL (Cu-OxLDL) and malondialdehyde (MDA)-LDL, IgG and IgM apolipoprotein B-100-immune complexes (IC/apoB). Traditional laboratory variables as well as C-reactive protein (CRP) and lipoprotein(a) [Lp(a)] were also measured. For the baseline variables, the distribution of OxPL/apoB and Lp(a) were skewed to lower values, and a strong correlation was noted between OxPL/apoB and Lp(a) (r = 0.94, p < 0.0001). No major associations were noted between OxLDL biomarkers and age, gender or dialytic age. There were also no correlations between OxLDL biomarkers and traditional risk factors, CRP, body mass index, serum creatinine, hypertension or intravenous iron therapy. Following dialysis, there as a significant reduction in OxPL/apoB (-7.5%, p = 0.048) and triglyceride levels (-10.8%, p = 0.005). All other OxLDL biomarkers, CRP, total cholesterol, LDL-C, HDL-C and apoB-100 increased significantly (range 6.3-26.9%, p value range 0.005 to <0.0001). Total protein plasma levels increased 8.8% (p = 0.014 compared to predialysis) following dialysis, consistent with a hemoconcentration effect of hemodialysis.In end-stage renal failure patients undergoing hemodialysis, a reduction in OxPL/apoB levels was noted, despite the hemoconcentrating and strong pro-oxidant milieu of hemodialysis. Studies in larger populations of end-stage renal failure patients are needed to assess whether these findings predict future clinical outcomes." @default.
• W1991036726 created "2016-06-24" @default.
• W1991036726 creator A5002000678 @default.
• W1991036726 creator A5018434005 @default.
• W1991036726 creator A5035031940 @default.
• W1991036726 creator A5051503802 @default.
• W1991036726 creator A5080819267 @default.
• W1991036726 creator A5083603948 @default.
• W1991036726 creator A5084291793 @default.
• W1991036726 creator A5087304926 @default.
• W1991036726 creator A5091030211 @default.
• W1991036726 date "2007-01-01" @default.
• W1991036726 modified "2023-10-18" @default.
• W1991036726 title "Oxidized Low-Density Lipoprotein Biomarkers in Patients with End-Stage Renal Failure: Acute Effects of Hemodialysis" @default.
• W1991036726 cites W1650965741 @default.
• W1991036726 cites W1978200035 @default.
• W1991036726 cites W1980975219 @default.
• W1991036726 cites W1990910626 @default.
• W1991036726 cites W1991981854 @default.
• W1991036726 cites W1996978408 @default.
• W1991036726 cites W2014324484 @default.
• W1991036726 cites W2024559429 @default.
• W1991036726 cites W2032678069 @default.
• W1991036726 cites W2043973087 @default.
• W1991036726 cites W2057280144 @default.
• W1991036726 cites W2064328290 @default.
• W1991036726 cites W2065726646 @default.
• W1991036726 cites W2069307786 @default.
• W1991036726 cites W2074675717 @default.
• W1991036726 cites W2082824437 @default.
• W1991036726 cites W2088400951 @default.
• W1991036726 cites W2091826616 @default.
• W1991036726 cites W2096695022 @default.
• W1991036726 cites W2103480977 @default.
• W1991036726 cites W2103858418 @default.
• W1991036726 cites W2108761207 @default.
• W1991036726 cites W2109629533 @default.
• W1991036726 cites W2111807513 @default.
• W1991036726 cites W2117260072 @default.
• W1991036726 cites W2122823225 @default.
• W1991036726 cites W2127273879 @default.
• W1991036726 cites W2130541883 @default.
• W1991036726 cites W2131385716 @default.
• W1991036726 cites W2134924827 @default.
• W1991036726 cites W2136128927 @default.
• W1991036726 cites W2148566344 @default.
• W1991036726 cites W2154718910 @default.
• W1991036726 cites W2165726012 @default.
• W1991036726 cites W2168723975 @default.
• W1991036726 cites W4236363489 @default.
• W1991036726 doi "https://doi.org/10.1159/000112465" @default.
• W1991036726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18075247" @default.
• W1991036726 hasPublicationYear "2007" @default.
• W1991036726 type Work @default.
• W1991036726 sameAs 1991036726 @default.
• W1991036726 citedByCount "12" @default.
• W1991036726 countsByYear W19910367262013 @default.
• W1991036726 countsByYear W19910367262014 @default.
• W1991036726 countsByYear W19910367262016 @default.
• W1991036726 countsByYear W19910367262017 @default.
• W1991036726 countsByYear W19910367262022 @default.
• W1991036726 crossrefType "journal-article" @default.
• W1991036726 hasAuthorship W1991036726A5002000678 @default.
• W1991036726 hasAuthorship W1991036726A5018434005 @default.
• W1991036726 hasAuthorship W1991036726A5035031940 @default.
• W1991036726 hasAuthorship W1991036726A5051503802 @default.
• W1991036726 hasAuthorship W1991036726A5080819267 @default.
• W1991036726 hasAuthorship W1991036726A5083603948 @default.
• W1991036726 hasAuthorship W1991036726A5084291793 @default.
• W1991036726 hasAuthorship W1991036726A5087304926 @default.
• W1991036726 hasAuthorship W1991036726A5091030211 @default.
• W1991036726 hasConcept C126322002 @default.
• W1991036726 hasConcept C134018914 @default.
• W1991036726 hasConcept C2776104379 @default.
• W1991036726 hasConcept C2776914184 @default.
• W1991036726 hasConcept C2778063415 @default.
• W1991036726 hasConcept C2778163477 @default.
• W1991036726 hasConcept C2779978075 @default.
• W1991036726 hasConcept C2780072125 @default.
• W1991036726 hasConcept C2781195455 @default.
• W1991036726 hasConcept C3019040382 @default.
• W1991036726 hasConcept C62746215 @default.
• W1991036726 hasConcept C71924100 @default.
• W1991036726 hasConceptScore W1991036726C126322002 @default.
• W1991036726 hasConceptScore W1991036726C134018914 @default.
• W1991036726 hasConceptScore W1991036726C2776104379 @default.
• W1991036726 hasConceptScore W1991036726C2776914184 @default.
• W1991036726 hasConceptScore W1991036726C2778063415 @default.
• W1991036726 hasConceptScore W1991036726C2778163477 @default.
• W1991036726 hasConceptScore W1991036726C2779978075 @default.
• W1991036726 hasConceptScore W1991036726C2780072125 @default.
• W1991036726 hasConceptScore W1991036726C2781195455 @default.
• W1991036726 hasConceptScore W1991036726C3019040382 @default.
• W1991036726 hasConceptScore W1991036726C62746215 @default.
• W1991036726 hasConceptScore W1991036726C71924100 @default.
• W1991036726 hasIssue "5-6" @default.
• W1991036726 hasLocation W19910367261 @default.
• W1991036726 hasLocation W19910367262 @default.

• next